These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 19218463)

  • 1. Receptor-mediated phagocytosis elicits cross-presentation in nonprofessional antigen-presenting cells.
    Giodini A; Rahner C; Cresswell P
    Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3324-9. PubMed ID: 19218463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments.
    Wan Y; Wu Y; Zhou J; Zou L; Liang Y; Zhao J; Jia Z; Engberg J; Bian J; Zhou W
    Eur J Immunol; 2005 Jul; 35(7):2041-50. PubMed ID: 15940671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of MHC class I recycling and Arf6 in cross-presentation by murine dendritic cells.
    Montealegre S; Abramova A; Manceau V; de Kanter AF; van Endert P
    Life Sci Alliance; 2019 Dec; 2(6):. PubMed ID: 31740564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
    Wang H; Yu X; Guo C; Zuo D; Fisher PB; Subjeck JR; Wang XY
    J Immunol; 2013 Dec; 191(12):6010-21. PubMed ID: 24218449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class I/peptide transfer between dendritic cells overcomes poor cross-presentation by monocyte-derived APCs that engulf dying cells.
    Qu C; Nguyen VA; Merad M; Randolph GJ
    J Immunol; 2009 Mar; 182(6):3650-9. PubMed ID: 19265143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for lipid bodies in the cross-presentation of phagocytosed antigens by MHC class I in dendritic cells.
    Bougnères L; Helft J; Tiwari S; Vargas P; Chang BH; Chan L; Campisi L; Lauvau G; Hugues S; Kumar P; Kamphorst AO; Dumenil AM; Nussenzweig M; MacMicking JD; Amigorena S; Guermonprez P
    Immunity; 2009 Aug; 31(2):232-44. PubMed ID: 19699172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the TAP-like transporter in antigen presentation and phagosome maturation.
    Lawand M; Evnouchidou I; Baranek T; Montealegre S; Tao S; Drexler I; Saveanu L; Si-Tahar M; van Endert P
    Mol Immunol; 2019 Sep; 113():75-86. PubMed ID: 29941219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent developments in MHC-class-I-mediated antigen presentation.
    Lehner PJ; Cresswell P
    Curr Opin Immunol; 2004 Feb; 16(1):82-9. PubMed ID: 14734114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells.
    Guermonprez P; Saveanu L; Kleijmeer M; Davoust J; Van Endert P; Amigorena S
    Nature; 2003 Sep; 425(6956):397-402. PubMed ID: 14508489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-presentation of epitopes on virus-like particles via the MHC I receptor recycling pathway.
    Win SJ; Ward VK; Dunbar PR; Young SL; Baird MA
    Immunol Cell Biol; 2011 Aug; 89(6):681-8. PubMed ID: 21221122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Antigen Export to the Cytosol During Cross-Presentation.
    Gros M; Amigorena S
    Front Immunol; 2019; 10():41. PubMed ID: 30745902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the Cell Biology of Antigen Cross-Presentation.
    Blander JM
    Annu Rev Immunol; 2018 Apr; 36():717-753. PubMed ID: 29490164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-presentation of synthetic long peptides by human dendritic cells: a process dependent on ERAD component p97/VCP but Not sec61 and/or Derlin-1.
    Ménager J; Ebstein F; Oger R; Hulin P; Nedellec S; Duverger E; Lehmann A; Kloetzel PM; Jotereau F; Guilloux Y
    PLoS One; 2014; 9(2):e89897. PubMed ID: 24587108
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Del Balzo D; Capmany A; Cebrian I; Damiani MT
    Front Immunol; 2021; 12():662096. PubMed ID: 33936099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are ERAD components involved in cross-presentation?
    Grotzke JE; Cresswell P
    Mol Immunol; 2015 Dec; 68(2 Pt A):112-5. PubMed ID: 26005101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells.
    Villadangos JA; Heath WR; Carbone FR
    Trends Immunol; 2007 Feb; 28(2):45-7. PubMed ID: 17197240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Access of soluble antigens to the endoplasmic reticulum can explain cross-presentation by dendritic cells.
    Ackerman AL; Kyritsis C; Tampé R; Cresswell P
    Nat Immunol; 2005 Jan; 6(1):107-13. PubMed ID: 15592474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A proteasome-dependent, TAP-independent pathway for cross-presentation of phagocytosed antigen.
    Merzougui N; Kratzer R; Saveanu L; van Endert P
    EMBO Rep; 2011 Dec; 12(12):1257-64. PubMed ID: 22037009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous antigens are processed through the endoplasmic reticulum-associated degradation (ERAD) in cross-presentation by dendritic cells.
    Imai J; Hasegawa H; Maruya M; Koyasu S; Yahara I
    Int Immunol; 2005 Jan; 17(1):45-53. PubMed ID: 15546887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.